Featured Products
- Adipose Tissue-Derived Stem Cells
- Human Neurons
- Mouse Probe
- Whole Chromosome Painting Probes
- Hepatic Cells
- Renal Cells
- In Vitro ADME Kits
- Tissue Microarray
- Tissue Blocks
- Tissue Sections
- FFPE Cell Pellet
- Probe
- Centromere Probes
- Telomere Probes
- Satellite Enumeration Probes
- Subtelomere Specific Probes
- Bacterial Probes
- ISH/FISH Probes
- Exosome Isolation Kit
- Human Adult Stem Cells
- Mouse Stem Cells
- iPSCs
- Mouse Embryonic Stem Cells
- iPSC Differentiation Kits
- Mesenchymal Stem Cells
- Immortalized Human Cells
- Immortalized Murine Cells
- Cell Immortalization Kit
- Adipose Cells
- Cardiac Cells
- Dermal Cells
- Epidermal Cells
- Peripheral Blood Mononuclear Cells
- Umbilical Cord Cells
- Monkey Primary Cells
- Mouse Primary Cells
- Breast Tumor Cells
- Colorectal Tumor Cells
- Esophageal Tumor Cells
- Lung Tumor Cells
- Leukemia/Lymphoma/Myeloma Cells
- Ovarian Tumor Cells
- Pancreatic Tumor Cells
- Mouse Tumor Cells
Hot Products
4q12 Tri-Color Rearrangement Probe
- Specification
- Q & A
- Customer Review
Cat.No.
FHPC-003
Description
The 4q12 Tri-Color Rearrangement FISH Probe is intended to detect rearrangements in chromosome 4q12 involving the FIP1L1-PDGFRA region, using FISH.
Chronic Eosinophilic Leukemia (CEL) is described by the World Health Organization (WHO) as a neoplasm in which clonal proliferation of eosinophil precursors results in prolonged eosinophilia. The chromosomal anomaly, del(4)(q12q12), results in a fusion of FIP1L1 and PDGFRA and is found in 40-60% of CEL syndromes. The Vysis LSI 4q12 Tri-Color Rearrangement Probe has been used to detect an approximately 800 kb deletion containing LNX and CHIC2 and subsequent fusion of FIP1L1 and PDGFRA. The current WHO classification system places myeloproliferative neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, or FGFR1 into their own detective category, while CEL lacking aberrations of these and several other genes falls into the CEL, not otherwise specified
Chronic Eosinophilic Leukemia (CEL) is described by the World Health Organization (WHO) as a neoplasm in which clonal proliferation of eosinophil precursors results in prolonged eosinophilia. The chromosomal anomaly, del(4)(q12q12), results in a fusion of FIP1L1 and PDGFRA and is found in 40-60% of CEL syndromes. The Vysis LSI 4q12 Tri-Color Rearrangement Probe has been used to detect an approximately 800 kb deletion containing LNX and CHIC2 and subsequent fusion of FIP1L1 and PDGFRA. The current WHO classification system places myeloproliferative neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, or FGFR1 into their own detective category, while CEL lacking aberrations of these and several other genes falls into the CEL, not otherwise specified
Size
20 Tests
Label
Red/Green
Specificity
Human
Locus
4q12
Usage

Storage
Store at minus 20 centigrade
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no.
If your paper has been published, please click here
to submit the PubMed ID of your paper to get a coupon.
Ask a Question
Write your own review